SCOTTSDALE, Ariz., May 6, 2010 (GLOBE NEWSWIRE) -- NightHawk Radiology Holdings, Inc. (Nasdaq:NHWK), the leading provider of radiology solutions to radiology groups across the United States, today announced its financial results for first quarter 2010 and provided an update on its dispute with St. Paul Radiology.
First Quarter 2010 Highlights
- Revenue was $36.5 million driven by total scan volume of approximately 765,000 scans.
- Total scan volume increased 6% from the year ago quarter.
- Final scan volumes increased 43% from the year ago quarter.
- Adjusted net income was $1.2 million, or $0.05 per diluted share. Adjusted net income excludes non-cash charges for stock compensation, amortization of intangible assets, malpractice reserve adjustments, effect of cancelled and ineffective interest rate swap contracts and severance costs. Also excluded in the first quarter of 2010 is a non-cash charge of $27.3 million ($16.9 million after-tax) resulting from the impairment of the company's intangible assets related to an ongoing negotiation towards a potential settlement of the company's dispute with St. Paul Radiology.
- GAAP net loss was $19.2 million, or $0.81 per diluted share. A reconciliation of adjusted net income to GAAP net loss is included in the tables attached to this press release.
- Cash flow from operations was $2.8 million.
- Cash and cash equivalents at March 31, 2010 totaled $33.9 million.
"We are pleased to report revenue and adjusted EPS in the middle of our guidance range. The solid quarterly results reflected good growth in preliminary volumes and robust growth in finals volumes," said David Engert, the company's president and chief executive officer.
Update on Dispute with St. Paul Radiology
As we have discussed in previous quarters, in September 2009, St. Paul Radiology notified us that it believes that we are in breach of certain of our obligations under our agreements with it. Although we continue to believe such claims of breach and their related allegations of damages are without merit, we have also continued in discussions with St. Paul Radiology in an attempt to resolve the dispute and discuss a mutually-acceptable dissolution of the original arrangement of the parties. In recent weeks, as a result of continued discussions between us and St. Paul Radiology, the parties have made substantial progress toward achieving a negotiated resolution. Although such resolution remains subject to successful negotiation and execution of final terms and definitive agreements, as part of the potential transaction as currently contemplated, the parties would terminate their existing relationships and unwind the July 2007 transaction. We would receive an up-front payment from St. Paul Radiology of $10 million and ongoing periodic payments from St. Paul Radiology totaling $14 million, resulting in aggregate consideration paid by St. Paul Radiology to us of $24 million. In addition, concurrently with the termination of the agreements with St. Paul Radiology, we would also enter into a separate agreement pursuant to which we would sell each of Midwest Physician Services, LLC and Emergency Radiology Services, LLC and their related assets for an aggregate consideration of $2 million payable to us upon closing. Finally, in addition to the amounts described above, if these transactions are consummated, we also expect to receive a tax refund equal to approximately $10 million resulting from the loss we will incur as a result of these transactions. If the transactions are consummated, we intend to pay the entire $36 million as principal repayments on our existing term loan, with $26 million to be paid following closing of the transactions and the remaining $10 million to be paid on or before June 30, 2011.
Please note that settlement negotiations are not complete and the parties may not be able to finalize a resolution. If a settlement is reached, it may be on terms different than those currently contemplated. For more information about the proposed transaction, the risks associated therewith and the associated current and future potential effects on our financial statements and future results of operations, please see the descriptions and risk factors set forth in our quarterly report for the period ending March 31, 2010 to be filed on or before May 10, 2010 as well as the other risk factors described in the company's periodic reports filed with the Securities and Exchange Commission from time to time. NightHawk does not undertake any obligation to publicly update its forward-looking statements based on events or circumstances after the date hereof.
Second Quarter 2010 Outlook
The company expects to see a seasonal sequential increase in scan volumes in the second quarter of 2010, offset by the continuing impact of price declines. Specifically, revenue for the second quarter of 2010 is expected to be in the range of $37.5 to $38.5 million and adjusted EPS is expected to be in the range of 6 to 7 cents. This outlook for the second quarter assumes that the existing agreements with St. Paul Radiology remain in place throughout the quarter. If a final definitive settlement is reached and the agreements with St. Paul Radiology are terminated, our financial results will no longer reflect the revenue and profits under those agreements from the transaction date forward.
Forward Looking Statements
This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995. These include statements regarding the company's outlook on its scan volume, revenue and adjusted earnings per share for future periods and any potential settlement or transactions with or related to St. Paul Radiology. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the statements made, including the risks associated with not consummating the transaction with St. Paul Radiology, general economic conditions, competitive conditions in the radiology industry, and regulatory risks. Other factors that could cause operating and financial results to differ are described in the company's periodic reports filed with the Securities and Exchange Commission ("SEC"). Other risks may be detailed from time to time in reports to be filed with the SEC. NightHawk does not undertake any obligation to publicly update its forward-looking statements based on events or circumstances after the date hereof.
Earnings Conference Call
The first quarter conference call will be held today, May 6, 2010 at 4:30 p.m. eastern time. A live webcast of the conference call, as well as a replay, will be available online on the company's corporate website at http://www.nighthawkrad.net. Participants can also access the call by dialing (800)762-8908 or (480)629-9774 (for international callers). A replay of the call will be available approximately two hours after the conclusion of the call and will remain available until midnight eastern time on Thursday, May 27, 2010. To access the replay, dial (800)406-7325 or (303)590-3030 (for international callers) and enter the conference ID number: 4285641
About NightHawk
NightHawk Radiology (Nasdaq:NHWK) is leading the transformation of the practice of radiology by providing high-quality, cost-effective solutions to radiology groups throughout the United States. NightHawk provides the most complete suite of solutions, including professional services, business services, and its advanced, proprietary clinical workflow technology, all designed to increase efficiencies and improve the quality of patient care and the lives of physicians who provide it. NightHawk's team of U.S. board-certified, state-licensed, and hospital-privileged physicians located in the United States, Australia, and Switzerland, provides services 24 hours a day, seven days a week, to approximately 26% of all hospitals in the United States. For more information, visit http://www.nighthawkrad.net.
The NightHawk Radiology Services logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=5531
Presentation of Non-GAAP Financial Information
The presentation of adjusted net income and adjusted earnings per diluted share are not measures of financial performance under GAAP and should not be considered a substitute for or superior to GAAP. Management believes these non-GAAP financial measures provide useful information to both management and investors by excluding certain expenses that may not be indicative of our core results and provide consistency in financial reporting. Specifically, the company's non-GAAP adjusted net income measure, and related adjusted earnings per diluted share, described in this release exclude the tax effected impact of (i) the non-cash charges related to our stock-based compensation, (ii) the non-cash expense associated with the amortization of intangibles associated with acquisitions, (iii) the non-cash expenses (or credits) associated with adjustments to our IBNR reserve (incurred but not reported medical liability reserves), (iv) the non-cash charges for the amortization of losses incurred on cancelled interest rate swap contracts and the non-cash gain (or loss) resulting from mark to market adjustments of our ineffective interest rate swap contracts, (v) the non-cash charges for goodwill and intangible asset impairments (vi) the non-cash charges and adjustments for restructuring activities, including severance and (vii) other expenses from time to time. These other expenses may occur in future periods, but the amounts recognized can vary from period to period and do not directly relate to the ongoing operations of the Company.
We exclude the non-cash charges related to our stock-based compensation due to the varying valuation methodologies, subjective assumptions and the variety of types of awards that companies can use when applying The Compensation Topic of the FASB Accounting Standards Codification (Topic 718) along with the fact that a substantial portion of our restricted stock units are held by our independent contractor physicians and require accounting treatment that differs from the accounting treatment for other stock-based awards held by employees.
The company provides non-GAAP adjusted net income and related adjusted earnings per diluted share as financial measures because management believes these measures provide greater transparency with respect to information used by management in its financial and operational decision making and to enhance investors' overall understanding of our current financial performance and our future prospects. For reconciliation of our non-GAAP financial measures to the most applicable GAAP financial measure, please refer to the information included in the attached tables of this press release and in the Investor Relations section of our corporate website.
"NHWKF"
| NIGHTHAWK RADIOLOGY HOLDINGS, INC. AND SUBSIDIARIES | ||
| CONSOLIDATED BALANCE SHEETS (unaudited) | ||
| ASSETS |
March 31, 2010 |
December 31, 2009 |
| (in thousands, except share data) | ||
| Current assets: | ||
| Cash and cash equivalents | $ 33,929 | $ 26,293 |
| Marketable securities | -- | 6,000 |
| Trade accounts receivable, net | 20,808 | 21,359 |
| Deferred income taxes | 2,759 | 910 |
| Prepaid expenses and other current assets | 6,398 | 4,702 |
| Total current assets | 63,894 | 59,264 |
| Property and equipment, net | 13,080 | 13,507 |
| Intangible assets, net | 43,529 | 72,550 |
| Deferred income taxes | 23,419 | 15,707 |
| Other assets, net | 3,334 | 4,646 |
| Total | $ 147,256 | $ 165,674 |
| LIABILITIES | ||
| Current liabilities: | ||
| Accounts payable | $ 5,910 | $ 6,130 |
| Accrued expenses and other liabilities | 3,736 | 3,473 |
| Accrued payroll and related benefits | 3,487 | 3,769 |
| Long-term debt, due within one year | 802 | 802 |
| Total current liabilities | 13,935 | 14,174 |
| Insurance reserve | 4,018 | 4,018 |
| Long-term debt | 77,203 | 77,404 |
| Other liabilities | 1,683 | 1,348 |
| Total liabilities | 96,839 | 96,944 |
| STOCKHOLDERS' EQUITY | ||
|
Common stock-150,000,000 shares authorized; $.001 par value; 23,590,251 and 23,558,890 shares issued and outstanding, respectively |
24 | 24 |
| Additional paid-in capital | 221,621 | 221,105 |
| Retained earnings (deficit) | (170,854) | (151,659) |
| Accumulated other comprehensive loss | (374) | (740) |
| Total stockholders' equity | 50,417 | 68,730 |
| Total | $ 147,256 | $ 165,674 |
| NIGHTHAWK RADIOLOGY HOLDINGS, INC. AND SUBSIDIARIES | ||
| CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) | ||
| Three months ended March 31, | ||
| 2010 | 2009 | |
| (in thousands, except per share data) | ||
| Service revenue | $ 36,548 | $ 38,798 |
| Operating costs and expenses: | ||
| Professional services | 17,464 | 16,656 |
| Sales, general, and administrative | 15,761 | 14,734 |
| Depreciation and amortization | 2,809 | 2,798 |
| Intangible asset and goodwill impairment | 27,326 | 68,718 |
| Total operating costs and expenses | 63,360 | 102,906 |
| Operating income (loss) | (26,812) | (64,108) |
| Other income (expense): | ||
| Interest expense | (3,324) | (2,302) |
| Interest income | 52 | 55 |
| Other, net | 10 | 10 |
| Total other income (expense) | (3,262) | (2,237) |
| Income (loss) before income taxes | (30,074) | (66,345) |
| Income tax expense (benefit) | (10,879) | (13,732) |
| Net income (loss) | $ (19,195) | $ (52,613) |
| Earnings (loss) per common share: | ||
| Basic | $ (0.81) | $ (1.97) |
| Diluted | $ (0.81) | $ (1.97) |
| Weighted averages of common shares outstanding: | ||
| Basic | 23,576,537 | 26,649,147 |
| Diluted | 23,576,537 | 26,649,147 |
| NIGHTHAWK RADIOLOGY HOLDINGS, INC. AND SUBSIDIARIES | ||
| CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) | ||
| Three months ended March 31, | ||
| 2010 | 2009 | |
| (in thousands) | ||
| Cash flows from operating activities: | ||
| Net income (loss) | $ (19,195) | $ (52,613) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||
| Depreciation and amortization | 2,809 | 2,798 |
| Intangible asset and goodwill impairment | 27,326 | 68,718 |
| Amortization of debt issuance costs and effect of interest rate swaps | 2,258 | 1,046 |
| Deferred income taxes | (9,790) | (14,287) |
| Non-cash stock compensation expense | 508 | 1,045 |
| Other, net | 224 | 416 |
| Changes in operating assets and liabilities: | ||
| Trade accounts receivable, net | 340 | 1,347 |
| Prepaid expenses and other assets | (1,699) | (1,097) |
| Accounts payable | 5 | (649) |
| Accrued expenses and other liabilities | 258 | 203 |
| Accrued payroll and related benefits | (287) | (733) |
| Net cash provided by operating activities | 2,757 | 6,194 |
| Cash flows from investing activities: | ||
| Purchase of marketable securities | -- | (4,991) |
| Proceeds from maturities of marketable securities | 6,000 | -- |
| Purchase of property and equipment | (929) | (1,110) |
| Net cash provided by (used in) investing activities | 5,071 | (6,101) |
| Cash flows from financing activities: | . | |
| Repayment of debt | (201) | (239) |
| Proceeds from exercise of stock options | 7 | 30 |
| Excess tax benefit from exercise of stock options | 2 | 5 |
| Purchase and retirement of common stock | -- | (6,452) |
| Net cash used in financing activities | (192) | (6,656) |
| Net increase (decrease) in cash and cash equivalents | 7,636 | (6,563) |
| Cash and cash equivalents—beginning of period | 26,293 | 47,160 |
| Cash and cash equivalents—end of period | $ 33,929 | $ 40,597 |
| NIGHTHAWK RADIOLOGY HOLDINGS, INC. AND SUBSIDIARIES | ||
| NON-GAAP RECONCILIATIONS | ||
| (in thousands, except share data) | ||
| Reconciliation of Net Income (Loss) to Adjusted Net Income: | ||
| Three Months Ended | ||
| March 31, 2010 | March 31, 2009 | |
| Net income (loss) | $ (19,195) | $ (52,613) |
| Tax effected impact of: | ||
| Non-cash stock-based compensation | 868 | 710 |
| Amortization of intangible assets | 1,050 | 1,260 |
| IBNR medical malpractice loss reserves | 0 | 282 |
| Effect of cancelled and ineffective interest rate swap contracts | 1,286 | 597 |
| Intangible asset and goodwill impairment | 16,926 | 53,761 |
| Severance costs | 270 | 0 |
| Adjusted net income | $ 1,205 | $ 3,997 |
| Reconciliation of Diluted earnings (loss) per share to Adjusted diluted earnings per share: | ||
| Three Months Ended | ||
| March 31, 2010 | March 31, 2009 | |
| Diluted earnings (loss) per share | $ (0.81) | $ (1.97) |
| Tax effected impact of: | ||
| Non-cash stock-based compensation | 0.04 | 0.02 |
| Amortization of intangible assets | 0.04 | 0.05 |
| IBNR medical malpractice loss reserves | 0.00 | 0.01 |
| Effect of cancelled and ineffective interest rate swap contracts | 0.05 | 0.02 |
| Intangible asset and goodwill impairment | 0.72 | 2.02 |
| Severance costs | 0.01 | 0.00 |
| Adjusted diluted earnings per share | $ 0.05 | $ 0.15 |
| Weighted average basic shares outstanding | 23,576,537 | 26,649,147 |
| Weighted average diluted shares outstanding, adjusted | 24,264,839 | 27,204,606 |
| NIGHTHAWK RADIOLOGY HOLDINGS, INC. AND SUBSIDIARIES | ||||
| HISTORICAL VOLUMES | ||||
| Growth Rates | ||||
| Quarter | Year | Total Volumes | Sequential | Year over Year |
| Q1 | 2009 | 722,321 | 1% | (3%) |
| Q2 | 2009 | 817,315 | 13% | 5% |
| Q3 | 2009 | 864,898 | 6% | 9% |
| Q4 | 2009 | 769,789 | (11%) | 7% |
| FY | 2009 | 3,174,323 | 5% | 5% |
| Q1 | 2010 | 765,151 | (1%) | 6% |